Prescription drug · NDA
Ziagen (Abacavir sulfate) NDC 49702-222
Abacavir sulfate 20 mg/mL · Solution · Oral · ViiV Healthcare Company
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 49702-222-48 | 4970202224849702022248 | 1 BOTTLE in 1 CARTON (49702-222-48) / 240 mL in 1 BOTTLEMarketed from Jan 28, 1999 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Ziagen
- Generic name (nonproprietary)
- abacavir sulfate
- Active ingredients
- Abacavir sulfate — 20 mg/mL
- Dosage form
- Solution
- Route
- Oral
- Labeler
- ViiV Healthcare CompanyNDC labeler code 49702
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 020978
- Marketing start
- Listing expires
- Other FDA classes
- Cytochrome P450 1A1 Inhibitors (Mechanism)Nucleoside Reverse Transcriptase Inhibitors (Mechanism)
- Identifiers
- Product ID 49702-222_35c3ae9e-3f9a-4e7f-b6b7-8674fd29f695SPL ID 35c3ae9e-3f9a-4e7f-b6b7-8674fd29f695SPL set ID ca73b519-015a-436d-aa3c-af53492825a1RxCUI 213461, 242680UNII J220T4J9Q2
- Pharmacologic class
- Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N449702022248followed by a unit qualifier and the quantityPackage 49702-0222-48. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
ZIAGEN tablets and oral solution, in combination with other antiretroviral agents, are indicated for the treatment of human immunodeficiency virus (HIV-1) infection. ZIAGEN, a nucleoside analogue human immunodeficiency virus (HIV-1) reverse transcriptase inhibitor, is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection. ( 1 )
Excerpt only. Read the full label for complete information.
About NDC 49702-222
- What is NDC 49702-222?
- 49702-222 is the product NDC for Ziagen (abacavir sulfate), Abacavir sulfate 20 mg/mL solution, listed with the FDA by ViiV Healthcare Company. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Ziagen (Abacavir sulfate).
- What is the active ingredient?
- Abacavir sulfate.
- Who is the labeler?
- ViiV Healthcare Company, NDC labeler code 49702. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Ziagen?
- None: this is the only finished product listed under this name.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.